Improving quality of care in patients with decompensated acute heart failure using a discharge checklist.


Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Historique:
received: 02 12 2018
revised: 22 02 2019
accepted: 21 05 2019
pubmed: 30 7 2019
medline: 28 11 2019
entrez: 30 7 2019
Statut: ppublish

Résumé

The use of a discharge checklist may decrease heart failure readmission rate. We aimed to evaluate the usefulness of a checklist in patients hospitalized for heart failure, in terms of mortality, cardiovascular mortality and readmission rates, and quality of care, including therapeutic optimization and careplan planning. We prospectively used a discharge checklist in 103 patients hospitalized for heart failure between July 2015 and January 2016. Quality of care and outcomes were compared with a retrospective cohort of 137 patients with same inclusion criteria, hospitalized between June 2014 and December 2014. The primary endpoints were total and cardiovascular mortality and readmissions for heart failure at 6months. The secondary endpoint was quality of care rendered, measured by evidence-based medications, appropriate medication uptitration and planned discharge care. At 6months, there were no differences between the checklist and control cohorts in the rates of all-cause mortality (10.7% vs. 13.1%; P=0.57), cardiovascular mortality (8.7% vs. 10.9%; P=0.58) and readmission (29.1% vs. 32.1%; P=0.62). Follow-up after discharge was better planned in the checklist group. The use of the checklist yielded therapeutic optimization with a higher dose of beta-blockers and renin-angiotensin-aldosterone system blockers, especially in patients with a reduced left ventricular ejection fraction (<50%) (P=0.03 and P=0.02, respectively). The use of a simple discharge checklist in patients with acute heart failure showed no benefit in terms of readmission and mortality rates; however, it yielded better quality of care, including therapeutic optimization and careplan planning.

Sections du résumé

BACKGROUND BACKGROUND
The use of a discharge checklist may decrease heart failure readmission rate.
AIMS OBJECTIVE
We aimed to evaluate the usefulness of a checklist in patients hospitalized for heart failure, in terms of mortality, cardiovascular mortality and readmission rates, and quality of care, including therapeutic optimization and careplan planning.
METHODS METHODS
We prospectively used a discharge checklist in 103 patients hospitalized for heart failure between July 2015 and January 2016. Quality of care and outcomes were compared with a retrospective cohort of 137 patients with same inclusion criteria, hospitalized between June 2014 and December 2014. The primary endpoints were total and cardiovascular mortality and readmissions for heart failure at 6months. The secondary endpoint was quality of care rendered, measured by evidence-based medications, appropriate medication uptitration and planned discharge care.
RESULTS RESULTS
At 6months, there were no differences between the checklist and control cohorts in the rates of all-cause mortality (10.7% vs. 13.1%; P=0.57), cardiovascular mortality (8.7% vs. 10.9%; P=0.58) and readmission (29.1% vs. 32.1%; P=0.62). Follow-up after discharge was better planned in the checklist group. The use of the checklist yielded therapeutic optimization with a higher dose of beta-blockers and renin-angiotensin-aldosterone system blockers, especially in patients with a reduced left ventricular ejection fraction (<50%) (P=0.03 and P=0.02, respectively).
CONCLUSIONS CONCLUSIONS
The use of a simple discharge checklist in patients with acute heart failure showed no benefit in terms of readmission and mortality rates; however, it yielded better quality of care, including therapeutic optimization and careplan planning.

Identifiants

pubmed: 31353278
pii: S1875-2136(19)30113-5
doi: 10.1016/j.acvd.2019.05.003
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

494-501

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Damien Legallois (D)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Cardiology, EA4650 (SEILIRM), FHU REMOD-VHF, 14000 Caen, France. Electronic address: damien.legallois@unicaen.fr.

Laure Chaufourier (L)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Cardiology, 14000 Caen, France.

Katrien Blanchart (K)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Cardiology, 14000 Caen, France.

Jean-Jacques Parienti (JJ)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Biostatistics and Clinical Research, 14000 Caen, France.

Annette Belin (A)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Cardiology, 14000 Caen, France.

Paul Milliez (P)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Cardiology, EA4650 (SEILIRM), FHU REMOD-VHF, 14000 Caen, France.

Rémi Sabatier (R)

Normandie Université, UNICAEN, CHU de Caen Normandie, Department of Cardiology, 14000 Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH